The chip market is experiencing a significant $1 trillion selloff, driven by AI-related volatility and highlighting the inherent risks faced by chipmakers in the current economic climate.
Tech stocks are experiencing a correction driven by an AI sell-off, prompting investors to reevaluate their portfolios amidst rising market volatility.
AI stocks are reflecting a market split reminiscent of the 1990s, with JPMorgan highlighting critical weeks ahead that could signal a concerning unwind in the sector.
Novo Nordisk's lawsuit against Eli Lilly over misleading advertising highlights the potential for volatility in pharmaceutical stocks, presenting both risks and opportunities for investors.
The ongoing U.S.-Iran conflict is contributing to rising oil prices, as indicated by the CW Index, which highlights the impact of geopolitical tensions on market stability.